Ujjwal Neogi

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2024;123:914-927
SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model.
Kaur Sardarni U; Ambikan AT; Acharya A; Johnson SD; Avedissian SN; Végvári Á; Neogi U; Byrareddy SN
Journal article: ISCIENCE. 2024;27(8):110501
Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
Rajaiah R; Pandey K; Acharya A; Ambikan A; Kumar N; Guda R; Avedissian SN; Montaner LJ; Cohen SM; Neogi U; Byrareddy SN
Article: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024;79(7):1938-1951
Association between gut microbiota development and allergy in infants born during pandemic-related social distancing restrictions
Korpela K; Hurley S; Ford SA; Franklin R; Byrne S; Lunjani N; Forde B; Neogi U; Venter C; Walter J; Hourihane J; O'Mahony L
Article: ISCIENCE. 2024;27(4):109346
Inflammatory, metabolic, and sex-dependent gene-regulatory dynamics of microglia and macrophages in neonatal hippocampus after hypoxia-ischemia
Di Martino E; Ambikan A; Ramskold D; Umekawa T; Giatrellis S; Vacondio D; Romero AL; Galan MG; Sandberg R; Aden U; Lauschke VM; Neogi U; Blomgren K; Kele J
Article: NATURE COMMUNICATIONS. 2024;15(1):2532
Parechovirus infection in human brain organoids: host innate inflammatory response and not neuro-infectivity correlates to neurologic disease
Capendale PE; Garcia-Rodriguez I; Ambikan AT; Mulder LA; Depla JA; Freeze E; Koen G; Calitz C; Sood V; de Sa RV; Neogi U; Pajkrt D; Sridhar A; Wolthers KC
Article: VIRUS RESEARCH. 2024;341:199306
Temporal cytokine storm dynamics in dengue infection predicts severity
Bhatt P; Varma M; Sood V; Ambikan A; Jayaram A; Babu N; Gupta S; Mukhopadhyay C; Neogi U
Article: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024;79(1):65-79
Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children
Lunjani N; Ambikan AT; Hlela C; Levin M; Mankahla A; Heldstab-Kast JI; Boonpiyathad T; Tan G; Altunbulakli C; Gray C; Nadeau KC; Neogi U; Akdis CA; O'Mahony L
Article: AGING CELL. 2023;22(10):e13951
Transcriptomics age acceleration in prolonged treated HIV infection
Mikaeloff F; Gelpi M; Escos A; Knudsen AD; Hogh J; Benfield T; de Magalhaes JP; Nielsen SD; Neogi U
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(37):e2304722120
Systems-level temporal immune- metabolic profile in Crimean-Congo hemorrhagic fever virus infection
Ambikan AT; Elaldi N; Akusjaervi SS; Bagci B; Pektas AN; Hewson R; Bagci G; Arasli M; Appelberg S; Mardinoglu A; Sood V; Vegvari A; Benfeitas R; Gupta S; Cetin I; Mirazimi A; Neogi U
Article: JMIR RESEARCH PROTOCOLS. 2023;12:e47018
Testing the Impact of Phone Texting Reminders for Children's Immunization Appointments in Rural Cameroon: Protocol for a Nonrandomized Controlled Trial
Ngah YE; Raoufi G; Amirkhani M; Esmaeili A; Nikooifard R; Mood SG; Rahmanian A; Boltena MT; Aga E; Neogi U; Mondinde GI; El-Khatib Z
Article: AIDS. 2023;37(7):1023-1033
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
Svensson Akusjarvi S; Krishnan S; Ambikan AT; Mikaeloff F; Munusamy Ponnan S; Vesterbacka J; Lourda M; Nowak P; Sonnerborg A; Neogi U
Article: CURRENT HIV/AIDS REPORTS. 2023;20(2):42-50
Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?
Akusjaervi SS; Neogi U
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(12):e2220320120
Functional SARS-CoV-2 cross-reactive CD4⁺ T cells established in early childhood decline with age
Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg K-J; Lund-Johansen F; Aleman S; Bjorkhem-Bergman L; Jenmalm MC; Ljunggren H-G; Buggert M; Karlsson AC
Article: ELIFE. 2023;12:e82785
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Hogh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Troseid M; Nielsen SD; Neogi U; Hens N
Article: FRONTIERS IN MICROBIOLOGY. 2023;14:1172340
Composition of subgingival microbiota associated with periodontitis and diagnosis of malignancy-a cross-sectional study
Narayanan A; Soder B; Meurman J; Lundmark A; Hu YOO; Neogi U; Yucel-Lindberg T
Article: GUT MICROBES. 2022;14(1):2073131
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2
Albrich WC; Ghosh TS; Ahearn-Ford S; Mikaeloff F; Lunjani N; Forde B; Suh N; Kleger G-R; Pietsch U; Frischknecht M; Garzoni C; Forlenza R; Horgan M; Sadlier C; Negro TR; Pugin J; Wozniak H; Cerny A; Neogi U; O'Toole PW; O'Mahony L
Article: LIFE SCIENCE ALLIANCE. 2022;5(9):e202201405
Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
Ambikan AT; Svensson-Akusjarvi S; Krishnan S; Sperk M; Nowak P; Vesterbacka J; Sonnerborg A; Benfeitas R; Neogi U
Article: CELL SYSTEMS. 2022;13(8):665-681.e4
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
Ambikan AT; Yang H; Krishnan S; Akusjarvi SS; Gupta S; Lourda M; Sperk M; Arif M; Zhang C; Nordqvist H; Ponnan SM; Sonnerborg A; Treutiger CJ; O'Mahony L; Mardinoglu A; Benfeitas R; Neogi U
Article: ELIFE. 2022;11:e76071
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjarvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):357
Peripheral blood CD4⁺CCR6⁺ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
Svensson Akusjarvi S; Krishnan S; Jutte BB; Ambikan AT; Gupta S; Rodriguez JE; Vegvari A; Sperk M; Nowak P; Vesterbacka J; Svensson JP; Sonnerborg A; Neogi U
Article: VIROLOGY. 2022;569:13-28
Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict β-coronaviral infection and replication
Sarkar L; Oko L; Gupta S; Bubak AN; Das B; Gupta P; Safiriyu AA; Singhal C; Neogi U; Bloom D; Banerjee A; Mahalingam R; Cohrs RJ; Koval M; Shindler KS; Pal D; Nagel M; Das Sarma J
Article: JOURNAL OF VIROLOGY. 2022;96(3):e0156821-e01521
Nucleoside-Modified mRNA Vaccines Protect IFNAR^-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
Appelberg S; John L; Pardi N; Vegvari A; Bereczky S; Ahlen G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sallberg M; Neogi U; Weissman D; Mirazimi A
Article: ISCIENCE. 2022;25(1):103607
Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
Akusjarvi SS; Ambikan AT; Krishnan S; Gupta S; Sperk M; Vegvari A; Mikaeloff F; Healy K; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):27
Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
Mikaeloff F; Akusjarvi SS; Ikomey GM; Krishnan S; Sperk M; Gupta S; Magdaleno GDV; Escos A; Lyonga E; Okomo MC; Tagne CT; Babu H; Lorson CL; Vegvari A; Banerjea AC; Kele J; Hanna LE; Singh K; de Magalhaes JP; Benfeitas R; Neogi U
Article: HRB OPEN RESEARCH. 2022;5:31
Impact of Long COVID on health and quality of life.
O' Mahony L; Buwalda T; Blair M; Forde B; Lunjani N; Ambikan A; Neogi U; Barrett P; Geary E; O'Connor N; Dineen J; Clarke G; Kelleher E; Horgan M; Jackson A; Sadlier C
Article: MICROBIOLOGY SPECTRUM. 2021;9(2):e0054921-e00521
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy
Saccon E; Bandera A; Sciume M; Mikaeloff F; Lashari AA; Aliberti S; Sachs MC; Billi F; Blasi F; Gabriel EE; Costantino G; De Roberto P; Krishnan S; Gori A; Peyvandi F; Scudeller L; Canetta C; Lorson CL; Valenti L; Singh K; Baldini L; Fracchiolla NS; Neogi U
Article: MICROBIOLOGY SPECTRUM. 2021;9(2):e0047021-e00421
Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
Ponnan SM; Thiruvengadam K; Tellapragada C; Ambikan AT; Narayanan A; Kathirvel S; Mathayan M; Shankar J; Rajaraman A; Amanulla MA; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Velu V; Shacklett B; Neogi U; Hanna LE
Article: HUMAN MOLECULAR GENETICS. 2021;30(21):2012-2026
Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction
Zhou X; Mikaeloff F; Curbo S; Zhao Q; Kuiper R; Vegvari A; Neogi U; Karlsson A
Article: AGING. 2021;13(19):22732-22751
The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome
Gelpi M; Mikaeloff F; Knudsen AD; Benfeitas R; Krishnan S; Akusjarvi SS; Hogh J; Murray DD; Ullum H; Neogi U; Nielsen SD
Article: JOURNAL OF VIROLOGY. 2021;95(18):e0047921-10.1128/jvi.00421
Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist
Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: ISCIENCE. 2021;24(5):102420
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
Saccon E; Chen X; Mikaeloff F; Rodriguez JE; Szekely L; Vinhas BS; Krishnan S; Byrareddy SN; Frisan T; Vegvari A; Mirazimi A; Neogi U; Gupta S
Article: CELL DEATH DISCOVERY. 2021;7(1):114
Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
Chen X; Saccon E; Appelberg KS; Mikaeloff F; Rodriguez JE; Vinhas BS; Frisan T; Vegvari A; Mirazimi A; Neogi U; Gupta S
Article: ACS INFECTIOUS DISEASES. 2021;7(5):1104-1115
Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
Ray S; Narayanan A; Giske CG; Neogi U; Sonnerborg A; Nowak P
Article: BMC INFECTIOUS DISEASES. 2021;21(1):214
Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
Obasa AE; Ambikan AT; Gupta S; Neogi U; Jacobs GB
Article: ISCIENCE. 2021;24(2):102111
Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
Sperk M; Mikaeloff F; Svensson-Akusjarvi S; Krishnan S; Ponnan SM; Ambikan AT; Nowak P; Sonnerborg A; Neogi U
Article: AIDS. 2021;35(2):227-234
High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden
Andersson E; Ambikan A; Brannstrom J; Aralaguppe SG; Yilmaz A; Albert J; Neogi U; Sonnerborg A
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:742736
Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals
Olund Villumsen S; Benfeitas R; Knudsen AD; Gelpi M; Hogh J; Thomsen MT; Murray D; Ullum H; Neogi U; Nielsen SD
Article: FRONTIERS IN MICROBIOLOGY. 2021;12:667718
Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
Bai X; Narayanan A; Nowak P; Ray S; Neogi U; Sonnerborg A
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:669347
Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
Saccon E; Mikaeloff F; Ivern PF; Vegvari A; Sonnerborg A; Neogi U; van Domselaar R
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:638144
Elevated Numbers of HIV-Specific Poly-Functional CD8⁺ T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals
Munusamy Ponnan S; Thiruvengadam K; Kathirvel S; Shankar J; Rajaraman A; Mathaiyan M; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Tripathy SP; Neogi U; Velu V; Hanna LE
Article: MOLECULAR & CELLULAR PROTEOMICS. 2021;20:100159
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
Krishnan S; Nordqvist H; Ambikan AT; Gupta S; Sperk M; Svensson-Akusjarvi S; Mikaeloff F; Benfeitas R; Saccon E; Ponnan SM; Rodriguez JE; Nikouyan N; Odeh A; Ahlen G; Asghar M; Sallberg M; Vesterbacka J; Nowak P; Vegvari A; Sonnerborg A; Treutiger CJ; Neogi U
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2020;36(12):1024-1032
Deep Profiling Identifies Selection of Nonsynonymous Amino Acid Substitutions in HIV-1 Envelope During Early Infection
Ashokkumar M; Pattabiraman S; Tripathy SP; Neogi U; Hanna LE
Article: EMERGING MICROBES AND INFECTIONS. 2020;9(1):1748-1760
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
Appelberg S; Gupta S; Svensson Akusjarvi S; Ambikan AT; Mikaeloff F; Saccon E; Vegvari A; Benfeitas R; Sperk M; Stahlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U
Article: BIOSENSORS AND BIOELECTRONICS. 2020;166:112442
Sub-attomole detection of HIV-1 using padlock probes and rolling circle amplification combined with microfluidic affinity chromatography
Soares RRG; Varela JC; Neogi U; Ciftci S; Ashokkumar M; Pinto IF; Nilsson M; Madaboosi N; Russom A
Article: PATHOGENS. 2020;9(5):E320-320
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
Neogi U; Hill KJ; Ambikan AT; Heng X; Quinn TP; Byrareddy SN; Soennerborg A; Sarafianos SG; Singh K
Article: SCIENTIFIC REPORTS. 2020;10(1):2747
In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
Article: CLINICAL INFECTIOUS DISEASES. 2020;70(4):615-627
The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis.
Tuddenham SA; Koay WLA; Zhao N; White JR; Ghanem KG; Sears CL; HIV Microbiome Re-analysis Consortium
Article: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2020;18:3734-3744
In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
Tiwari R; Mishra AR; Mikaeloff F; Gupta S; Mirazimi A; Byrareddy SN; Neogi U; Nayak D
Article: FRONTIERS IN MICROBIOLOGY. 2020;11:438
Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
Obasa AE; Mikasi SG; Brado D; Cloete R; Singh K; Neogi U; Jacobs GB
Article: METABOLITES. 2019;9(10):E210-210
Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy
Babu H; Sperk M; Ambikan AT; Rachel G; Viswanathan VK; Tripathy SP; Nowak P; Hanna LE; Neogi U
Article: AIDS. 2019;33(11):1757-1763
HIV elite control is associated with reduced TRAILshort expression
Paim AC; Cummins NW; Natesampillai S; Garcia-Rivera E; Kogan N; Neogi U; Sonnerborg A; Sperk M; Bren GD; Deeks S; Polley E; Badley AD
Article: VIRUSES. 2019;11(9):E806-806
MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
Aralaguppe SG; Ambikan AT; Ashokkumar M; Kumar MM; Hanna LE; Amogne W; Sonnerborg A; Neogi U
Article: BMC INFECTIOUS DISEASES. 2019;19(1):569
A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort
Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Marrone G; Grossmann S; Neogi U; Tegbaru B; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2019;35(6):572-576
Mutations in Long Terminal Repeats κB Transcription Factor Binding Sites in Plasma Virus Among South African People Living with HIV-1
Obasa AE; Ashokkumar M; Neogi U; Jacobs GB
Article: JOURNAL OF VIROLOGY. 2019;93(9):e00077-e00019
HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness
van Domselaar R; Njenda DT; Rao R; Sonnerborg A; Singh K; Neogi U
Article: LAB ON A CHIP. 2019;19(9):1657-1664
Microfluidic centrifugation assisted precipitation based DNA quantification
Banerjee I; Aralaguppe SG; Lapins N; Zhang W; Kazemzadeh A; Sonnerborg A; Neogi U; Russom A
Article: AIDS. 2019;33(3):588-592
Strain-specific effect on biphasic DNA binding by HIV-1 integrase
Hill KJ; Rogers LC; Njenda DT; Burke DH; Sarafianos SG; Sonnerborg A; Neogi U; Singh K
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1965
Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
Babu H; Ambikan AT; Gabriel EE; Akusjarvi SS; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Article: FRONTIERS IN MICROBIOLOGY. 2019;10:1227
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
Singh K; Gallazzi F; Hill KJ; Burke DH; Lange MJ; Quinn TP; Neogi U; Sonnerborg A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2721-2728
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes
Njenda DT; Aralaguppe SG; Singh K; Rao R; Sonnerborg A; Sarafianos SG; Neogi U
Article: AIDS. 2018;32(12):1589-1598
The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages
Missailidis C; Neogi U; Stenvinkel P; Troseid M; Nowak P; Bergman P
Article: SCIENTIFIC REPORTS. 2018;8(1):7556
Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Abdurahman S; Marrone G; Neogi U; Tegbaru B; Sonnerborg A
Article: JOURNAL OF VIROLOGY. 2018;92(9):e00063-e00018
Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses
Ashokkumar M; Aralaguppe SG; Tripathy SP; Hanna LE; Neogi U
Article: SCIENTIFIC REPORTS. 2018;8(1):4709
Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa
Brado D; Obasa AE; Ikomey GM; Cloete R; Singh K; Engelbrecht S; Neogi U; Jacobs GB
Article: AIDS. 2018;32(4):469-476
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes
Neogi U; Singh K; Aralaguppe SG; Rogers LC; Njenda DT; Sarafianos SG; Hejdeman B; Sonnerborg A
Article: SCIENTIFIC REPORTS. 2018;8(1):2363
Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C from East Africa
Siddik AB; Haas A; Rahman MS; Aralaguppe SG; Amogne W; Bader J; Klimkait T; Neogi U
Article: MEDICINE (UNITED KINGDOM). 2018;97(5):e9759
Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males A cross-sectional study
Sperk M; Zhang W; Nowak P; Neogi U
Article: EBIOMEDICINE. 2018;27:40-50
Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
Zhang W; Ambikan AT; Sperk M; van Domselaar R; Nowak P; Noyan K; Russom A; Sonnerborg A; Neogi U
Article: FRONTIERS IN MICROBIOLOGY. 2018;9:1754
Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
Rogers L; Obasa AE; Jacobs GB; Sarafianos SG; Sonnerborg A; Neogi U; Singh K
Article: FRONTIERS IN MICROBIOLOGY. 2018;9:2358
Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
Zhang W; Akusjarvi SS; Sonnerborg A; Neogi U
Article: HIV MEDICINE. 2017;18(9):677-684
A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model
Brannstrom J; Sonnerborg A; Svedhem V; Neogi U; Marrone G
Article: SCIENTIFIC REPORTS. 2017;7(1):6371
Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
Neogi U; Siddik AB; Kalaghatgi P; Gisslen M; Bratt G; Marrone G; Sonnerborg A
Article: SCIENTIFIC REPORTS. 2017;7(1):6269
Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers
Vesterbacka J; Rivera J; Noyan K; Parera M; Neogi U; Calle M; Paredes R; Sonnerborg A; Noguera-Julian M; Nowak P
Article: SCIENTIFIC REPORTS. 2017;7(1):666
Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
Zhang W; Morshed MM; Noyan K; Russom A; Sonnerborg A; Neogi U
Article: PLOS ONE. 2017;12(7):e0180140
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
Haggblom A; Santacatterina M; Neogi U; Gisslen M; Hejdeman B; Flamholc L; Sonnerborg A
Article: JOURNAL OF MEDICAL VIROLOGY. 2017;89(1):106-111
Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa
Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quinones-Mateu ME; Soennerborg A; Neogi U
Article: PLOS ONE. 2017;12(6):e0178942
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
Svard J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sonnerborg A
Article: JOURNAL OF VIROLOGICAL METHODS. 2016;236:98-104
Multiplexed next-generation sequencing and de novo assembly to obtain near full-length HIV-1 genome from plasma virus
Aralaguppe SG; Siddik AB; Manickam A; Ambikan AT; Kumar MM; Fernandes SJ; Amogne W; Bangaruswamy DK; Hanna LE; Sonnerborg A; Neogi U
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2016;32(5):471-474
Phylogenetic Analysis of Ethiopian HIV-1 Subtype C Near Full-Length Genomes Reveals High Intrasubtype Diversity and a Strong Geographical Cluster
Amogne W; Bontell I; Grossmann S; Aderaye G; Lindquist L; Sonnerborg A; Neogi U
Article: THE LANCET INFECTIOUS DISEASES. 2016;16(5):565-575
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
Gregson J; Tang M; Ndembi N; Hamers RL; Rhee S-Y; Marconi VC; Diero L; Brooks K; Theys K; de Wit TFR; Arruda M; Garcia F; Monge S; Gunthard HF; Hoffmann CJ; Kanki PJ; Kumarasamy N; Kerschberger B; Mor O; Charpentier C; Todesco E; Rokx C; Gras L; Halvas EK; Sunpath H; Di Carlo D; Antinori A; Andreoni M; Latini A; Mussini C; Aghokeng A; Sonnerborg A; Neogi U; Fessel WJ; Agolory S; Yang C; Blanco JL; Juma JM; Smit E; Schmidt D; Watera C; Asio J; Kirungi W; Tostevin A; El-Hay T; Clumeck N; Goedhals D; van Vuuren C; Bester PA; Sabin C; Mukui I; Santoro MM; Perno CF; Hunt G; Morris L; Camacho R; de Oliveira T; Pillay D; Schulter E; Murakami-Ogasawara A; Reyes-Teran G; Romero K; Avila-Rios S; Sirivichayakul S; Ruxrungtham K; Mekprasan S; Dunn D; Kaleebu P; Raizes E; Kantor R; Shafer RW; Gupta RK
Article: THE LANCET HIV. 2016;3(4):e166-e174
Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden
Haggblom A; Svedhem V; Singh K; Sonnerborg A; Neogi U
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):367-371
Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries
Neogi U; Haggblom A; Singh K; Rogers LC; Rao SD; Amogne W; Schuelter E; Zazzi M; Arnold E; Sarafianos SG; Sonnerborg A
Article: BMJ OPEN. 2016;6(1):e008795
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?
Gupta S; Palchaudhuri R; Neogi U; Srinivasa H; Ashorn P; De Costa A; Kallander C; Shet A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2016;32(1):80-84
Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa
Neogi U; Engelbrecht S; Claassen M; Jacobs GB; van Zyl G; Preiser W; Sonnerborg A
Article: AIDS. 2015;29(18):2409-2418
Gut microbiota diversity predicts immune status in HIV-1 infection
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svard J; Rudi K; Sonnerborg A
Article: TROPICAL MEDICINE AND INTERNATIONAL HEALTH. 2015;20(11):1462-1472
Virological efficacy with first-line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression
Shet A; Neogi U; Kumarasamy N; DeCosta A; Shastri S; Rewari BB
Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2015;18(1):20035
Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management
Grossmann S; Nowak P; Neogi U
Article: INTERVIROLOGY. 2015;58(1):1-5
Performance of Genotypic Tools for Prediction of Tropism in HIV-1 Subtype C V3 Loop Sequences
Gupta S; Neogi U; Srinivasa H; Shet A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2014;69(12):3349-3355
Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries
Ekici H; Rao SD; Sonnerborg A; Ramprasad VL; Gupta R; Neogi U
Article: THE BMJ. 2014;349:g5978
Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India
Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V
Article: INDIAN PEDIATRICS. 2014;51(10):801-803
Genetic Factors Associated with Slow Progression of HIV among Perinatally-Infected Indian Children
Chaudhuri RP; Neogi U; Rao SD; Shet A
Article: AIDS. 2014;28(15):2319-2322
Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients
Neogi U; Rao SD; Bontell I; Verheyen J; Rao VR; Gore SC; Soni N; Shet A; Schuelter E; Ekstrand ML; Wondwossen A; Kaiser R; Madhusudhan MS; Prasad VR; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2014;30(6):586-591
Phylogenetic Characterization of Six Full-Length HIV-1 Subtype C Molecular Clones from Three Patients: Identification of Rare Subtype C Strains Containing Two NF-κB Motifs in the Long Terminal Repeat
Hanna LE; Neogi U; Ranga U; Swaminathan S; Prasad VR
Article: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999). 2014;65(4):397-404
HIV-1 Coreceptor Tropism in India: Increasing Proportion of X4-Tropism in Subtype C Strains Over Two Decades
Gupta S; Neogi U; Srinivasa H; Banerjea AC; Shet A
Article: PLOS ONE. 2014;9(9):e107074
The gp120 Protein Is a Second Determinant of Decreased Neurovirulence of Indian HIV-1C Isolates Compared to Southern African HIV-1C Isolates
Rao VR; Neogi U; Eugenin E; Prasad VR
Article: ANTIVIRAL THERAPY. 2014;19(8):813-818
Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India
Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A
Article: PLOS ONE. 2014;9(6):e99390
Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
Neogi U; Haggblom A; Santacatterina M; Bratt G; Gisslen M; Albert J; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013;29(12):1613-1616
Genetic Architecture of HIV Type 1 Nef and Tat from HLA-B57-Typed Long-Term Survivors in an Indian Cohort of Perinatally HIV-Infected Children
Neogi U; Palchaudhuri R; Bommana S; Shet A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013;68(9):2003-2006
High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings
Gupta S; Neogi U; Srinivasa H; Shet A
Article: RETROVIROLOGY. 2013;10:61
Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence
Rao VR; Neogi U; Talboom JS; Padilla L; Rahman M; Fritz-French C; Gonzalez-Ramirez S; Verma A; Wood C; Ruprecht RM; Ranga U; Azim T; Joska J; Eugenin E; Shet A; Bimonte-Nelson H; Tyor WR; Prasad VR
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2013;32(5):e227-e229
Effectiveness of First-line Antiretroviral Therapy and Acquired Drug Resistance Among HIV-1-infected Children in India
Shet A; Neogi U; Sahoo PN; De Costa A
Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2013;16(1):18472
Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
Neogi U; Shet A; Sahoo PN; Bontell I; Ekstrand ML; Banerjea AC; Sonnerborg A
Article: PLOS ONE. 2013;8(1):e55421
Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study
Neogi U; Heylen E; Shet A; Chandy S; Shamsunder R; Soennerborg A; Ekstrand ML
Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(53):44714-44735
Multiple NF-κB Sites in HIV-1 Subtype C Long Terminal Repeat Confer Superior Magnitude of Transcription and Thereby the Enhanced Viral Predominance
Bachu M; Yalla S; Asokan M; Verma A; Neogi U; Sharma S; Murali RV; Mukthey AB; Bhatt R; Chatterjee S; Rajan RE; Cheedarla N; Yadavalli VS; Mahadevan A; Shankar SK; Rajagopalan N; Shet A; Saravanan S; Balakrishnan P; Solomon S; Vajpayee M; Satish KS; Kundu TK; Jeang K-T; Ranga U
Article: INTERNATIONAL JOURNAL OF MICROBIOLOGY RESEARCH. 2012;136(6):956-962
Dried blood spot HIV-1 RNA quantification: A useful tool for viral load monitoring among HIV-infected individuals in India
Neogi U; Gupta S; Rodridges R; Sahoo PN; Rao SD; Rewari BB; Shastri S; De Costa A; Shet A
Article: BMC INFECTIOUS DISEASES. 2012;12:317
High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naive perinatally-infected children and adolescents with HIV-1 subtype C infection
Neogi U; Sahoo PN; De Costa A; Shet A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012;28(9):1152-1156
Genetic Characterization of HIV Type 1 Tat Exon 1 from a Southern Indian Clinical Cohort: Identification of Unique Epidemiological Signature Residues
Neogi U; Gupta S; Sahoo PN; Shet A; Rao SD; Ranga U; Prasad VR
Article: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999). 2012;59(4):347-353
Higher Prevalence of Predicted X4-Tropic Strains in Perinatally Infected Older Children With HIV-1 Subtype C in India
Neogi U; Sahoo PN; Arumugam K; Sonnerborg A; De Costa A; Shet A
Article: PLOS ONE. 2012;7(6):e39819
Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C
Neogi U; Bontell I; Shet A; De Costa A; Gupta S; Diwan V; Laishram RS; Wanchu A; Ranga U; Banerjea AC; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2011;27(11):1249-1253
Characterization of HIV Type 1 Subtype C protease Gene: Selection of L63P Mutation in Protease Inhibitor-Naive Indian Patients
Neogi U; Sahoo PN; Kumar R; De Costa A; Shet A
Article: AIDS. 2011;25(8):1123-1126
Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance
Neogi U; Shet A; Shamsundar R; Ekstrand ML
Article: REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL. 2011;44(3):309-312
Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India
Goud R; Gupta S; Neogi U; Agarwal D; Naidu K; Chalannavar R; Subhaschandra G
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010;26(12):1299-1305
Diversity of HIV Type 1 Long Terminal Repeat (LTR) Sequences Following Mother-to-Child Transmission in North India
Neogi U; Sharma Y; Sood V; Wanchu A; Banerjea AC
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010;26(10):1097-1101
Naturally Occurring Polymorphisms and Primary Drug Resistance Profile Among Antiretroviral-Naive Individuals in Bangalore, India
Neogi U; Prarthana BS; Gupta S; D'souza G; De Costa A; Kuttiatt VS; Arumugam K; Shet A
Article: AIDS RESEARCH AND THERAPY. 2010;7:28
Genetic and functional analysis of HIV-1 Rev Responsive Element (RRE) sequences from North-India
Sharma Y; Neogi U; Sood V; Banerjee S; Samrat S; Wanchu A; Singh S; Banerjea AC
Article: AIDS RESEARCH AND THERAPY. 2010;7:24
Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India
Neogi U; Prarthana SB; D'Souza G; DeCosta A; Kuttiatt VS; Ranga U; Shet A
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2010;10:25
Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India - the HIVIND study protocol
De Costa A; Shet A; Kumarasamy N; Ashorn P; Eriksson B; Bogg L; Diwan VK
Article: AIDS RESEARCH AND THERAPY. 2009;6:28
Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage.
Neogi U; Sood V; Chowdhury A; Das S; Ramachandran VG; Sreedhar VK; Wanchu A; Ghosh N; Banerjea AC
Article: JOURNAL OF GENERAL VIROLOGY. 2009;90(Pt 11):2768-2776
Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr
Bano AS; Sood V; Neogi U; Goel N; Kuttiat VS; Wanchu A; Banerjea AC
Article: BIOINFORMATION. 2009;4(3):90-91
The expanding HIV-1 epidemic aggravates therapeutics and vaccine development programs in India.
Neogi U
Article: ARCHIVES OF VIROLOGY. 2008;153(10):1961-1966
Novel HIV-1 long terminal repeat (LTR) sequences of subtype B and mosaic intersubtype B/C recombinants in North India
Neogi U; Sood V; Goel N; Wanchu A; Banerjea AC
Visa fler

Alla övriga publikationer

Book chapter: ADVANCES IN IMMUNOLOGY. 2024;p. 73-100
System-level integrative omics analysis to identify the virus-host immunometabolic footprint during infection.
Ambikan A; Akusjärvi SS; Sperk M; Neogi U
Preprint: RESEARCH SQUARE. 2023
Parechovirus infection in human brain organoids: host innate inflammatory response and not neuro-infectivity correlates to neurologic disease
Capendale PE; García-Rodríguez I; Ambikan AT; Mulder LA; Depla JA; Freeze E; Koen G; Calitz C; Sood V; de Sá RV; Neogi U; Pajkrt D; Srid A; Wolthers KC
Preprint: RES SQ. 2023;RES SQ
Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications.
Acharya A; Ambikan AT; Thurman M; Malik MR; Dyavar SR; Végvári Á; Neogi U; Byrareddy SN
Preprint: MEDRXIV. 2023
Gut microbiome predicts atopic diseases in an infant cohort with reduced bacterial exposure due to social distancing
Korpela K; Hurley S; Ford SA; Franklin R; Byrne S; Lunjani N; Forde B; Neogi U; Venter C; Walter J; Hourihane J; O’Mahony L
Letter: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;77(5):1623-1625
Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19
Sadlier C; Albrich WC; Neogi U; Lunjani N; Horgan M; O'Toole PW; O'Mahony L
Review: PHARMACOLOGICAL REPORTS. 2022;74(2):273-296
Antiviral drug research for Japanese encephalitis: an updated review
Joe S; Salam AAA; Neogi U; Babu NN; Mudgal PP
Preprint: HRB OPEN RES. 2022
Impact of Long COVID on health and quality of life
O’ Mahony L; Buwalda T; Blair M; Forde B; Lunjani N; Ambikan A; Neogi U; Barrett P; Geary E; O'Connor N; Dineen J; Clarke G; Kelleher E; Horgan M; Jackson A; Sadlier C
Review: JOURNAL OF PROTEOME RESEARCH. 2020;19(11):4259-4274
Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
Sperk M; van Domselaar R; Rodriguez JE; Mikaeloff F; Vinhas BS; Saccon E; Sonnerborg A; Singh K; Gupta S; Vegvari A; Neogi U
Letter: JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH. 2020;10(3):192-193
The Association between Out-of-Pocket Expenditure and COVID-19 Mortality Globally
El-Khatib Z; Otu A; Neogi U; Yaya S
Corrigendum: SCIENTIFIC REPORTS. 2020;10(1):13607
In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha (vol 10, 2747, 2020)
Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
Letter: ECLINICALMEDICINE. 2020;23:100430
The disproportionate effect of COVID-19 mortality on ethnic minorities: Genetics or health inequalities?
El-Khatib Z; Jacobs GB; Ikomey GM; Neogi U
Editorial comment: ECLINICALMEDICINE. 2020;18:100251
Following the path: Increasing trends of HIV-1 drug resistance in China
Gupta S; Neogi U
Meeting abstract: VIRUS EVOLUTION. 2019;5:S2
Near full-length HIV-1 genome sequencing in newly diagnosed individuals in Sweden
Andersson E; Aralaguppe S; Thebo L; Sonnerborg A; Neogi U; Albert J
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2018;19(7):E2000-2000
Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
Sperk M; van Domselaar R; Neogi U
Corrigendum: SCIENTIFIC REPORTS. 2018;8(1):6262
Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South Africa (vol 8, 2018)
Brado D; Obasa AE; Ikomey GM; Cloete R; Singh K; Engelbrecht S; Neogi U; Jacobs GB
Letter: AIDS. 2014;28(17):2635-2636
Minor viral population with drug-resistant mutation and risk of persistent low-level viremia or 'blips' in HIV-1 subtype C
Neogi U; Sonnerborg A
Review: VIRUSES. 2014;6(9):3535-3562
Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
Singh K; Flores JA; Kirby KA; Neogi U; Sonnerborg A; Hachiya A; Das K; Arnold E; McArthur C; Parniak M; Sarafianos SG
Letter: JOURNAL OF INFECTIOUS DISEASES. 2013;208(5):866-867
High Viremia in HIV-1 Subtype C Infection and Spread of the Epidemic
Neogi U; Palchaudhuri R; Shet A
Thesis / dissertation: 2013
Translational genomics of HIV-1 subtype C in India : molecular phylogeny and drug resistance
Neogi, Ujjwal
Meeting abstract: RETROVIROLOGY. 2012;9:p151
Emergence of unique recombinant forms (URFs) in Indian HIV-1 epidemic: data from nationwide clinical cohort between 2007 and 2011
Neogi U; Gupta S; Shet A; De Costa A; Laishram RL; Wanchu A; Diwan V; Banerjea AC; Sonnerborg A
Review: INDIAN JOURNAL OF MEDICAL RESEARCH. 2011;134(6):769-778
Genetic architecture of HIV-1 genes circulating in north India & their functional implications
Neogi U; Sood V; Ronsard L; Singh J; Lata S; Ramachandran VG; Das S; Wanchu A; Banerjea AC
Meeting abstract: RETROVIROLOGY. 2009;6:p375
Emergence of HIV-1 circulatory recombinant forms (CRFs) and unique recombinant forms (URFs) in North India: functional and pathogenic implications
Neogi U; Sood V; Bano AS; Wanchu A; Banerjea AC
Published conference paper: INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY. 2009;47(6):424-431
Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: Functional and pathogenic implications of genetic variation
Neogi U; Sood V; Banerjee S; Ghosh N; Verma S; Samrat S; Sharma Y; Saxena A; Husain S; Ramachandran VG; Das S; Sreedhar VK; Goel N; Wanchu A; Banerjea AC
Review: INDIAN JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2008;45(3):141-148
Host genes that affect progression of AIDS/HIV in India and novel gene therapeutic approaches against HIV
Sood V; Rathore A; Husain S; Khan S; Patra S; Shankar V; Kumar H; Rani N; Bano AS; Neogi U; Ramachandran VG; Banerjea AC
Visa fler

Forskningsbidrag

Indoor biomass burning contributes to significant particulate matter exposure, chronic human health burden, and an economic drain in rural households
Swedish Research Council
1 January 2023 - 31 December 2026
Potentiating host immuno-metabolism as a novel approach toward reservoir eradication and functional cure in HIV-1 infection
Swedish Research Council
1 December 2021 - 30 November 2025
Comprehensive mapping of metabolic perturbations in emerging and re-emerging RNA viruses for novel therapeutic approaches
Swedish Research Council
1 December 2021 - 30 November 2024
Characterization of susceptibility and resistance to novel categories of anti-HIV compounds
Swedish Research Council
1 January 2021 - 31 December 2023
A clinical trans-omics multidisciplinary study to understand the role of antiretroviral therapy in premature ageing of the immune system in HIV-infection
Vetenskapsrådet
1 December 2018 - 30 November 2023
A clinical trans-omics multidisciplinary study to understand the role of antiretroviral therapy in premature ageing of the immune system in HIV-infection
Swedish Research Council
1 December 2018 - 30 November 2023
A multi-omics system biology approach to identify disease control mechanisms in HIV-1 positive Elite Controllers and the importance for HIV-cure
Swedish Research Council
1 January 2018 - 31 December 2021
Unravilling the mechanisms of natural control and long term successful ART in HIV-1 infection: prospects for HIV-1 cure and vaccine development
Swedish Research Council
1 January 2018 - 31 December 2020
Development of a molecular surveillance phylogeographic tool to track HIV transmission networks in Bangladesh
Swedish Research Council
1 January 2016 - 31 December 2018

Anställningar

Lektor, Laboratoriemedicin, Karolinska Institutet, 2024-

Examina och utbildning

Docent, Virologi, Karolinska Institutet, 2018
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2013

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI